Health
Cellid, IVI sign research service contract to evaluate immunogenicity of COVID-19 vaccine – News-Medical.Net
Cellid and the International Vaccine Institute have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine “AdCLD-CoV19″….
Cellid and the International Vaccine Institute (IVI) have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine “AdCLD-CoV19”.
Cellid and IVI announced on January 4 that they have signed a research service contract to cooperate in the clinical development of the “AdCLD-CoV19”, a COVID-19 vaccine being developed by Cellid.
Under this contract, IVI will analyze samples from Phase 1/2a clinical trials of Cellid’s COVID-19 vaccine “AdCLD-CoV19” to determine…
-
General19 hours agoGather Round’s first ever Sicko Saturday treats Adelaide Oval to a day of gloriously bad football
-
General19 hours agoTrump’s trade team chases 90 deals in 90 days
-
General22 hours agoSikh Lane a WA first as Dongara puts multicultural history on the map
-
General19 hours agoClick-bait Bandt | The Spectator Australia